C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
0.805
AUD
-1.23%
Market Cap:
AU$89.5m
Balance Sheet
Balance Sheet Decomposition
Cyclopharm Ltd
Cyclopharm Ltd
Balance Sheet Decomposition is not available for
Cyclopharm Ltd
Cyclopharm Ltd
Balance Sheet
Cyclopharm Ltd
Cyclopharm Ltd
Currency: AUD
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
4
|
5
|
2
|
2
|
2
|
1
|
3
|
6
|
5
|
9
|
6
|
13
|
2
|
29
|
20
|
12
|
21
|
|
| Cash |
0
|
0
|
1
|
4
|
5
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
2
|
29
|
20
|
12
|
21
|
|
| Cash Equivalents |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
6
|
5
|
9
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
3
|
4
|
4
|
5
|
4
|
4
|
4
|
4
|
4
|
3
|
4
|
4
|
5
|
6
|
4
|
9
|
8
|
8
|
8
|
8
|
|
| Accounts Receivables |
2
|
3
|
3
|
4
|
4
|
4
|
4
|
3
|
4
|
3
|
4
|
4
|
5
|
6
|
4
|
5
|
5
|
5
|
6
|
5
|
|
| Other Receivables |
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
3
|
2
|
2
|
3
|
|
| Inventory |
1
|
2
|
2
|
3
|
3
|
3
|
2
|
3
|
3
|
2
|
2
|
3
|
3
|
3
|
2
|
5
|
6
|
8
|
10
|
13
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Total Current Assets |
4
|
7
|
8
|
12
|
12
|
8
|
9
|
9
|
7
|
9
|
13
|
11
|
17
|
15
|
20
|
16
|
43
|
37
|
30
|
42
|
|
| PP&E Net |
1
|
1
|
1
|
3
|
5
|
10
|
10
|
10
|
1
|
1
|
1
|
2
|
3
|
2
|
6
|
6
|
6
|
7
|
9
|
13
|
|
| PP&E Gross |
1
|
1
|
1
|
3
|
5
|
10
|
10
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
7
|
9
|
13
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
16
|
16
|
16
|
13
|
16
|
|
| Intangible Assets |
0
|
1
|
2
|
3
|
2
|
3
|
3
|
3
|
4
|
1
|
1
|
2
|
3
|
5
|
4
|
4
|
5
|
5
|
5
|
5
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Assets |
6
N/A
|
9
+67%
|
11
+19%
|
19
+69%
|
20
+6%
|
22
+13%
|
21
-4%
|
22
+2%
|
12
-45%
|
11
-8%
|
17
+51%
|
16
-1%
|
23
+42%
|
24
+1%
|
33
+38%
|
28
-13%
|
56
+97%
|
50
-11%
|
46
-7%
|
62
+35%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
4
|
3
|
4
|
4
|
6
|
6
|
6
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
0
|
2
|
6
|
5
|
4
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Liabilities |
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
0
|
0
|
3
|
2
|
3
|
4
|
|
| Total Current Liabilities |
2
|
4
|
2
|
2
|
4
|
8
|
7
|
6
|
5
|
3
|
3
|
4
|
5
|
5
|
3
|
6
|
7
|
8
|
9
|
11
|
|
| Long-Term Debt |
0
|
5
|
2
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
4
|
4
|
4
|
8
|
|
| Deferred Income Tax |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
2
N/A
|
10
+309%
|
4
-63%
|
6
+52%
|
6
+4%
|
8
+47%
|
7
-20%
|
6
-10%
|
5
-12%
|
3
-40%
|
3
+7%
|
4
+15%
|
6
+55%
|
7
+6%
|
9
+43%
|
11
+20%
|
13
+14%
|
13
+3%
|
14
+5%
|
19
+42%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
6
|
1
|
8
|
11
|
11
|
11
|
13
|
15
|
15
|
15
|
15
|
15
|
22
|
22
|
32
|
32
|
63
|
63
|
64
|
87
|
|
| Retained Earnings |
3
|
1
|
0
|
2
|
4
|
4
|
3
|
2
|
7
|
7
|
2
|
2
|
4
|
4
|
8
|
14
|
19
|
26
|
31
|
44
|
|
| Other Equity |
1
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
3
N/A
|
1
N/A
|
7
N/A
|
13
+78%
|
14
+7%
|
14
-1%
|
15
+6%
|
16
+7%
|
7
-58%
|
8
+18%
|
13
+69%
|
12
-5%
|
17
+38%
|
17
-1%
|
23
+36%
|
17
-26%
|
43
+152%
|
37
-15%
|
32
-12%
|
43
+32%
|
|
| Total Liabilities & Equity |
6
N/A
|
9
+67%
|
11
+19%
|
19
+69%
|
20
+6%
|
22
+13%
|
21
-4%
|
22
+2%
|
12
-45%
|
11
-8%
|
17
+51%
|
16
-1%
|
23
+42%
|
24
+1%
|
33
+38%
|
28
-13%
|
56
+97%
|
50
-11%
|
46
-7%
|
62
+35%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
30
|
30
|
37
|
37
|
37
|
37
|
45
|
59
|
58
|
58
|
60
|
60
|
68
|
69
|
78
|
80
|
93
|
93
|
94
|
111
|
|
Switch to:
Switch to:
See Also
Discover More
